Study: NCT02385071

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: Treatment C (3\*50 mg dispersible SMV tablets dispersed in water under fed conditions).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: Treatment C (3\*50 mg dispersible SMV tablets dispersed in water under fed conditions).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: Treatment C (3\*50 mg dispersible SMV tablets dispersed in water under fed conditions).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment D
Description: \*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment D
Description: \*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment D
Description: \*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment D
Description: \*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment D
Description: \*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment D
Description: \*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment E
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fasted conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment E
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fasted conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment E
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fasted conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment E
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fasted conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment E
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fasted conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment E
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with water or 3\*50 mg dispersible SMV tablets dispersed in water under fasted conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment F
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with yoghurt or 3\*50 mg dispersible SMV tablets dispersed in apple juice under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment F
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with yoghurt or 3\*50 mg dispersible SMV tablets dispersed in apple juice under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment F
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with yoghurt or 3\*50 mg dispersible SMV tablets dispersed in apple juice under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment F
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with yoghurt or 3\*50 mg dispersible SMV tablets dispersed in apple juice under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment F
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with yoghurt or 3\*50 mg dispersible SMV tablets dispersed in apple juice under fed conditions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment F
Description: 3\*50 mg SMV capsules (including 50 mini-tablets of 1 mg each) with yoghurt or 3\*50 mg dispersible SMV tablets dispersed in apple juice under fed conditions.